Department of Neurosurgery, St. Olavs University Hospital, Trondheim, Norway.
Department of Neurosurgery, Sahlgrenska University Hospital, Gothenburg.
Ann Oncol. 2017 Aug 1;28(8):1942-1948. doi: 10.1093/annonc/mdx230.
Infiltrating low-grade gliomas (LGG; WHO grade 2) typically present with seizures in young adults. LGGs grow continuously and usually transform to higher grade of malignancy, eventually causing progressive disability and premature death. The effect of up-front surgery has been controversial and the impact of molecular biology on the effect of surgery is unknown. We now present long-term results of upfront surgical resection compared with watchful waiting in light of recently established molecular markers.
Population-based parallel cohorts were followed from two Norwegian university hospitals with different surgical treatment strategies and defined geographical catchment regions. In region A watchful waiting was favored while early resection was favored in region B. Thus, the treatment strategy in individual patients depended on their residential address. The inclusion criteria were histopathological diagnosis of supratentorial LGG from 1998 through 2009 in patients 18 years or older. Follow-up ended 1 January 2016. Making regional comparisons, the primary end-point was overall survival.
A total of 153 patients (66 from region A, 87 from region B) were included. Early resection was carried out in 19 (29%) patients in region A compared with 75 (86%) patients in region B. Overall survival was 5.8 years (95% CI 4.5-7.2) in region A compared with 14.4 years (95% CI 10.4-18.5) in region B (P < 0.01). The effect of surgical strategy remained after adjustment for molecular markers (P = 0.001).
In parallel population-based cohorts of LGGs, early surgical resection resulted in a clinical relevant survival benefit. The effect on survival persisted after adjustment for molecular markers.
浸润性低级别胶质瘤(LGG;WHO 分级 2 级)通常在年轻成人中表现为癫痫发作。LGG 持续生长,通常会转化为更高恶性程度,最终导致进行性残疾和过早死亡。初始手术的效果存在争议,分子生物学对手术效果的影响尚不清楚。我们现在根据最近建立的分子标志物,展示了初始手术切除与观察等待相比的长期结果。
基于人群的平行队列从挪威的两所大学医院进行随访,这些医院具有不同的手术治疗策略和明确的地理收治区域。在 A 区,观察等待是首选策略,而在 B 区则倾向于早期切除。因此,患者的治疗策略取决于他们的居住地址。纳入标准为 1998 年至 2009 年间在年龄为 18 岁或以上的患者中,经组织病理学诊断为幕上 LGG。随访截止日期为 2016 年 1 月 1 日。为了进行区域比较,主要终点是总生存。
共纳入 153 名患者(A 区 66 名,B 区 87 名)。A 区有 19 名(29%)患者接受了早期切除,而 B 区有 75 名(86%)患者接受了早期切除。A 区的总生存时间为 5.8 年(95%CI 4.5-7.2),B 区为 14.4 年(95%CI 10.4-18.5)(P<0.01)。在调整了分子标志物后,手术策略的效果仍然存在(P=0.001)。
在 LGG 的平行基于人群的队列中,早期手术切除可带来临床相关的生存获益。在调整了分子标志物后,对生存的影响仍然存在。